HKEX: 1666 - Tong Ren Tang Technologies Co. Ltd.

Yield per half year: -12.22%
Dividend yield: +3.30%
Sector: Healthcare

Tong Ren Tang Technologies Co. Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
12.15 36.52 -66.72% 16.37 -25.78%
P/S 1.06 7.13 -85.16%
P/BV 0.7431 3.65 -79.67%
P/FCF 19.63 0.253 7658.95%
Ev/Ebitda 3.96 2.91 36.18%
Ev/S 0.8932 16.43 -94.56%
Ev/FCF 13.42 -1.58 -948.79%
E/P 0.0667 0.0333 100.08%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
22.55 -9.78 -330.63% 23.07 -2.25%
ROE 8.83 4.47 97.33%
ROA 4.54 3 51.52%
ROIC 0 0 0%
ROS 8.71 -11.06 -178.73%
ROCE 0 0.1527 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.04 0.7586 37.22% 1.13 -7.62%
Nеt Debt/Ebitda 0 0.0296 -100%
Debt/Ratio 0.1177 0.1204 -2.21%
Debt/Equity 0.3995 0.6971 -42.69%
Debt/Net Income 2.69 1.5 79.16%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
8.25/10
3.3 5.74 -42.47% 3.53 -6.54%
Number of years of dividend growth 1 1.23 -18.64%
DSI 0.7857 0.5838 34.59%
Average dividend growth 1.09 3.99 -72.69%
Average percentage for 5 years 3.53 4.99 -29.26%
Average percentage for payments 38.8 25.09 54.63%
Difference from average difference in sector -2.44

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
7/10
51.31 -10.8 -575.09%
Growth impulse Ebitda in 5 years 37.11 -43.85 -184.63%
Growth impulse Net Income in 5 years 41.31 147.44 -71.98%
Growth impulse FCF in 5 years -42.44 10.26 -513.65%
Growth impulse EPS in 5 years 41.31 -241.16 -117.13%
IP Score
5.93/10

Similar companies

WuXi Biologics (Cayman) Inc.

Hangzhou Tigermed Consulting Co., Ltd

CSPC Pharmaceutical Group Limited

WuXi AppTec Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription